HMRN information

Set within the former adjacent UK Cancer Networks of Yorkshire and the Humber & Yorkshire Coast, the Haematological Malignancy Research Network (HMRN) was established in 2004 to provide robust generalizable data to inform clinical practice and research. It is a collaboration between researchers in the Epidemiology & Statistics Group (ECSG) at the University of York, a unified Clinical Network operating across 14 hospitals, and an integrated Haematological Malignancy Diagnostic Service (HMDS) at St James’s Hospital in Leeds.

HMRN region: participating hospitals

Map of the HMRN region

Covering a population of 3.8 million, HMRN collects detailed information about all patients diagnosed with a haematological malignancy within the HMRN region, accruing around 2,300 new diagnoses each year. The population has a similar socio-demographic profile to the country as a whole, and HMRN’s maturing data present an increasingly valuable resource to address real questions of concern to haematologists, commissioners and health service researchers – locally, nationally and internationally.

Browser not supported

Your web browser does not support Scalable Vector Graphics (SVG), which is required to display this content.

You can upgrade to any one of these free web browsers to view this content.

Google Chrome (recommended)

Urban / Rural HMRN Region Map
HMRN % England %
Village, Hamlet & Isolated
Dwellings - Sparse
0.8 0.7
Village, Hamlet & Isolated
Dwellings - Less Sparse
7.8 8.4
Town & Fringe - Sparse
0.6 0.5
Town & Fringe - Less Sparse
10.9 9.0
Urban > 10K - Sparse
0.4 0.2
Urban > 10K - Less Sparse
79.6 81.2
Urban / Rural HMRN Region Map
HMRN % England %
1 (Affluent)
16.2 20.0
21.2 20.0
18.1 20.0
19.1 20.0
5 (Deprived)
25.4 20.0

Browser not supported

Your web browser does not support Scalable Vector Graphics (SVG), which is required to display this content.

You can upgrade to any one of these free web browsers to view this content.

Google Chrome (recommended)

Within HMRN, as a matter of policy, all haematological malignancy diagnoses, including disease progressions and transformations, are centrally coded using the latest World Health Organization (WHO) classifications by clinical staff at HMDS’s laboratory; which houses all of the relevant technology and expertise required for diagnosis and on-going monitoring and is at the forefront of developing diagnostic and prognostic tumour biomarkers. Network clinical teams from the 14 hospitals, which function through 5 adult multidisciplinary teams (MDTs) and a network-wide paediatric oncology service, work to common national guidelines covering investigation, treatment and follow-up.

Following diagnosis, patients are individually tracked, and full details of all treatments, responses and outcomes are collected to clinical trial standards. HMRN operates with Section 251 support under the UK’s National Health Service (NHS) Act 2006, enabling the Health and Social Care Information Centre (HSCIC) to provide additional nationwide information on all deaths, cancer registrations, and hospital in-patient and out-patient episodes.

Where next?


How are the disorders HMRN research classified?

The data we collect

What data do we collect for the different disorders we research?


What individual projects are happening within HMRN?

Access the HMRN members functions.


If you are a member of the Clinical Network, complete the form below to register as an HMRN user.

Confirm Email:
MDT (Multi Disciplinary Team):
I Agree to the Terms of Service:

Reset the password for your HMRN account.

Enter your username below. An email will then be sent to the address associated with your account containing a link to reset your password.


If you are unsure of your username, please contact us at

If you have any queries or comments, please feel free to contact us using the details below.

Email us

Write to us

Haematological Malignancy Research Network
Epidemiology & Cancer Statistics Group
Department of Health Sciences
Area 3
Seebohm Rowntree Building
YO10 5DD

I understand that, in accordance with the Data Protection Act 1998, by logging into this site I agree that:

  1. The data must not be published or shared with other third parties outside of the Network without first obtaining permission from the Network Audit Haematology Group.
  2. No attempt will be made to identify individual patients or to contact them and confidentiality of information will be preserved at all times.
  3. I am currently employed by an NHS trust operating in the area of the combined Yorkshire and Humber and Yorkshire Coast Cancer Networks.
  4. Any public domain reports or papers resulting from analyses of the provided data will be shared with HMRN prior to publication and appropriate acknowledgement given.